RegulatorySpineTop Stories

CoreLink Announces Commercial Launch Of CentraFix™ Midline Fixation System

CoreLink reveals the CentraFix Midline Fixation System, expanding their comprehensive Pedicle Screw System offering. The system features modular cobalt chrome tulip heads allowing for intraoperative flexibility and increased visualization in smaller incisions.

ST. LOUIS, Dec. 2, 2021 /PRNewswire/ — CoreLink, LLC, a leading designer and manufacturer of spinal implant systems, today announced the commercial launch and 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the CoreLink CentraFix™ Midline Fixation System.

CentraFix is a posterior thoracolumbar pedicle screw system designed for less invasive spinal fixation often used with a medial-to-lateral approach, known as cortical bone trajectory (CBT). This technique maximizes contact of the pedicle screw with cortical bone and is intended to reduce incision size, limit muscular and vascular injury, and improve initial fixation. CentraFix features modular cobalt chrome tulip heads and titanium alloy screw shanks in various lengths and diameters, designed specifically to allow screw placement in denser cortical bone.

“The CentraFix System provides unmatched intraoperative visualization and surgical flexibility for the midline approach,” said Jay Bartling, CEO of CoreLink. “Our in-house development and manufacturing have allowed us to produce our most innovative fixation system to date.”

The CentraFix low-profile, modular tulip heads have been designed to minimize tissue disruption and simplify distraction without compromising strength. Self-drilling, self-tapping cortical screw threading provides easy screw starting in the intended trajectory and allow for 360° motion with a 60° cone of angulation. The system includes 4.75mm and 5.5mm rod options, set screws designed to minimize tulip splay, and a robust offering of ergonomic and intuitive instrumentation to facilitate fast and efficient surgery.

About CoreLink
CoreLink, known as The Source for Spine™, internally designs and manufactures more than 99% of its broad portfolio of spinal implant systems. With a unique heritage that combines old-world craftsmanship with state-of-the-art manufacturing, we collaborate with surgeons to develop and deliver effective surgical solutions and improve the lives of patients. Learn more at


Related Links

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button